Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://alvinbqsr458640.theideasblog.com/41026454/tirzepatide-a-new-frontier-in-diabetes-treatment